title: Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop.
abstract: Several important genes that are involved in inflammation and tissue remodeling are switched on by virtue of CRE response elements in their promoters. The upstream signaling mechanisms that inflammatory mediators use to activate cAMP response elements (CREs) are poorly understood. Endothelin (ET) is an important vasoactive mediator that plays roles in inflammation, vascular remodeling, angiogenesis, and carcinogenesis by activating 7 transmembrane G protein-coupled receptors (GPCR). Here we characterized the mechanisms ET-1 uses to regulate CRE-dependent remodeling genes in pulmonary vascular smooth muscle cells. These studies revealed activation pathways involving a cyclooxygenase-2 (COX-2)/prostacyclin receptor (IP receptor) autocrine loop and an interlinked calcium-dependent pathway. We found that ET-1 activated several CRE response genes in vascular smooth muscle cells, particularly COX-2, amphiregulin, follistatin, inhibin-beta-A, and CYR61. ET-1 also activated two other genes epiregulin and HB-EGF. Amphiregulin, follistatin, and inhibin-beta-A and epiregulin were activated by an autocrine loop involving cPLA2, arachidonic acid release, COX-2-dependent PGI(2) synthesis, and IP receptor-linked elevation of cAMP leading to CRE transcription activation. In contrast COX-2, CYR61, and HB-EGF transcription were regulated in a calcium-dependent, COX-2 independent, manner. Observations with IP receptor antagonists and COX-2 inhibitors were confirmed with IP receptor or COX-2-specific small interfering RNAs. ET-1 increases in intracellular calcium and gene transcription were dependent upon ET(a) activation and calcium influx through T type voltage-dependent calcium channels. These studies give important insights into the upstream signaling mechanisms used by G protein-coupled receptor-linked mediators such as ET-1, to activate CRE response genes involved in angiogenesis, vascular remodeling, inflammation, and carcinogenesis.
authors.affiliation: Division of Respiratory Medicine, Centre for Respiratory Research, University of Nottingham, City Hospital Site, Hucknall Road, Nottingham, UK. karl.deacon@nottingham.ac.uk
authors.forename: Karl
authors.initials: K
authors.lastname: Deacon
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Knox
mesh_terms: D019898:Autocrine Communication / Q000502:physiology*; D002118:Calcium / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000378:metabolism; D019332:Endothelin-1 / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D054467:Phospholipases A2 / Q000378:metabolism; D054510:Phospholipases A2, Cytosolic / Q000378:metabolism; D011651:Pulmonary Artery / Q000166:cytology; D044006:Receptors, Epoprostenol / Q000378:metabolism; D020218:Response Elements / Q000235:genetics; D015854:Up-Regulation; D014652:Vascular Diseases / Q000235:genetics*
chemical_list: D019332:Endothelin-1; D044006:Receptors, Epoprostenol; D000242:Cyclic AMP; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D054467:Phospholipases A2; D054510:Phospholipases A2, Cytosolic; D002118:Calcium
references.citation: J Cardiovasc Pharmacol. 1995;26 Suppl 3:S348-50
references.pmid: 8587411
references.citation: Br J Pharmacol. 1999 Oct;128(3):721-9
references.pmid: 10516654
references.citation: Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
references.pmid: 11483993
references.citation: J Med Chem. 2000 Mar 23;43(6):1041-4
references.pmid: 10737736
references.citation: J Cardiovasc Pharmacol. 1995;26 Suppl 3:S346-7
references.pmid: 8587410
references.citation: Cell Signal. 2004 Dec;16(12):1387-96
references.pmid: 15381254
references.citation: FEBS J. 2007 Jul;274(13):3210-7
references.pmid: 17565598
references.citation: Res Exp Med (Berl). 1997;196(6):327-37
references.pmid: 9089881
references.citation: J Exp Med. 1990 Dec 1;172(6):1741-8
references.pmid: 1701822
references.citation: Eur J Pharmacol. 1992 Apr 10;225(4):347-50
references.pmid: 1323478
references.citation: J Cardiovasc Pharmacol. 1993;22 Suppl 8:S235-8
references.pmid: 7509954
references.citation: J Neurosci. 2001 Nov 15;21(22):8842-53
references.pmid: 11698596
references.citation: Agents Actions Suppl. 1995;45:269-73
references.pmid: 7717188
references.citation: Exp Cell Res. 2003 Mar 10;284(1):2-13
references.pmid: 12648462
references.citation: J Allergy Clin Immunol. 2005 Feb;115(2):287-94
references.pmid: 15696083
references.citation: Biochem Biophys Res Commun. 1989 Jun 30;161(3):1220-7
references.pmid: 2662974
references.citation: Endocrinology. 1993 Feb;132(2):524-9
references.pmid: 7678793
references.citation: Eur J Pharmacol. 1993 Jun 24;237(2-3):275-81
references.pmid: 8365455
references.citation: Br J Pharmacol. 2005 Nov;146(6):903-12
references.pmid: 16151434
references.citation: FEBS Lett. 1997 Jun 23;410(1):22-4
references.pmid: 9247115
references.citation: Biochem Pharmacol. 2002 Aug 1;64(3):425-31
references.pmid: 12147293
references.citation: Br J Pharmacol. 1997 Sep;122(2):217-24
references.pmid: 9313928
references.citation: J Cell Biol. 1993 Aug;122(4):933-40
references.pmid: 8349739
references.citation: J Hum Hypertens. 1992 Dec;6 Suppl 2:S3-8
references.pmid: 1289511
references.citation: J Cell Sci. 2007 Apr 1;120(Pt 7):1256-66
references.pmid: 17376964
references.citation: Mol Hum Reprod. 2006 Oct;12(10):593-9
references.pmid: 16888076
references.citation: Prostaglandins. 1994 Jan;47(1):55-9
references.pmid: 8140262
references.citation: Biochem Biophys Res Commun. 1993 Mar 31;191(3):823-30
references.pmid: 8466520
references.citation: Am J Physiol. 1998 Aug;275(2):L322-9
references.pmid: 9700093
references.citation: Biochem Biophys Res Commun. 1992 Oct 30;188(2):719-26
references.pmid: 1280120
references.citation: Am J Respir Cell Mol Biol. 1995 May;12(5):557-66
references.pmid: 7742018
references.citation: Cancer Res. 2000 Dec 15;60(24):6886-9
references.pmid: 11156386
references.citation: Am J Physiol. 1995 Feb;268(2 Pt 1):L192-200
references.pmid: 7864140
references.citation: Br J Cancer. 2008 Nov 18;99(10):1656-67
references.pmid: 18941464
references.citation: Life Sci. 1998;62(17-18):1485-9
references.pmid: 9585123
references.citation: Front Biosci. 2007 Jan 01;12:1814-32
references.pmid: 17127423
references.citation: Biochem Biophys Res Commun. 2003 Feb 21;301(4):1109-15
references.pmid: 12589827
references.citation: Annu Rev Biochem. 1999;68:821-61
references.pmid: 10872467
references.citation: Nature. 1988 Mar 31;332(6163):411-5
references.pmid: 2451132
references.citation: Heart Vessels. 1993;8(3):121-7
references.pmid: 8407721
references.citation: Int J Cancer. 2006 Jul 1;119(1):49-59
references.pmid: 16450371
references.citation: FEBS J. 2006 Dec;273(23):5479-89
references.pmid: 17116246
references.citation: J Pharmacol Exp Ther. 1994 Dec;271(3):1483-8
references.pmid: 7996461
references.citation: Mol Pharmacol. 1999 May;55(5):902-9
references.pmid: 10220569
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2006 Aug;75(2):81-90
references.pmid: 16890416
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L680-90
references.pmid: 12740215
references.citation: J Clin Invest. 1989 Mar;83(3):1061-5
references.pmid: 2522102
references.citation: J Cardiovasc Pharmacol. 1995;26 Suppl 3:S156-8
references.pmid: 8587350
references.citation: J Biol Chem. 1997 May 30;272(22):14489-96
references.pmid: 9162092
references.citation: Biochem Biophys Res Commun. 2004 Nov 12;324(2):829-34
references.pmid: 15474502
references.citation: Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1077-83
references.pmid: 18388330
references.citation: J Neurochem. 2005 May;93(3):664-73
references.pmid: 15836625
references.citation: FASEB J. 2006 Sep;20(11):1936-8
references.pmid: 16877529
references.citation: Trends Cell Biol. 2002 Jun;12(6):258-66
references.pmid: 12074885
references.citation: J Vasc Surg. 1991 Jul;14(1):1-9
references.pmid: 2061949
references.citation: Circ Res. 2005 Apr 29;96(8):864-72
references.pmid: 15774856
references.citation: Biochem Biophys Res Commun. 2007 Mar 23;354(4):885-91
references.pmid: 17274952
references.citation: Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:467-70
references.pmid: 2889338
references.citation: Cell Signal. 2003 Jun;15(6):597-604
references.pmid: 12681447
references.citation: Br J Pharmacol. 2006 Feb;147(3):335-45
references.pmid: 16331286
references.citation: Biochem Pharmacol. 2008 Feb 15;75(4):942-55
references.pmid: 18036509